Citi announced that it worked exclusively with five Black-owned firms to syndicate a $2.5 billion bond issuance, reinforcing the firm’s commitment to increasing racial equity

$125 million refinancing substantially improves Innocoll’s liquidity, enabling further investment in pharmaceutical technology portfolio and growth plan Innocoll Biotherapeutics plc, a specialty pharmaceutical company and

Ribbon Biolabs, the DNA synthesis company, announced the successful close of EUR 18 million in its Series A funding round from a consortium of European